PsychU

Sorry, this content is no longer available.

Explore Other Content
Welcome to PsychU!
Improving mental health care...together

Influence of Comorbidities on Outcomes in Patients With Bipolar I Disorder

Podcast July 9, 2025
  1. Home
  2. Patient & Caregiver Resource Center
  3. Influence of Comorbidities on Outcomes in Patients With Bipolar I Disorder

The impact of comorbidities on patient outcomes is profound, as these additional psychiatric conditions can exacerbate symptoms, complicate treatment plans, and adversely affect the overall prognosis and quality of life for individuals with Bipolar I Disorder. In this podcast, Dr. Joseph Goldberg will delve into how co-occurring psychiatric conditions influence patient health. A comprehensive understanding and effective management of these comorbidities are crucial for optimizing patient care and enhancing long-term outcomes.

Featuring

Joseph-Goldberg

Joseph Goldberg, MD

Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai

More
Joseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. He attended college at the University of Chicago, graduate school in neuroscience at the University of Illinois, and medical school at Northwestern University. He completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He has published over 200 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, most recently “Managing the Side Effects of Psychotropic Medications, 2nd edition” published in 2019 by American Psychiatric Publishing, and the forthcoming “Practical Psychopharmacology” by Cambridge University Press. He serves on the Board of Directors for the American Society of Clinical Psychopharmacology and is on the editorial boards for a number of peer-reviewed journals. His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly’s “America’s Top Doctors.”

Joseph F. Goldberg is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

April 2025 US.CORP.X.25.00086

Upcoming Events

View All Upcoming Events

On-Demand Webinars

View On-Demand Webinar Library

Stay Connected: